Manager, Marketing Strategy & Commercialization
CytovaleHighlight
Summary
About the Role
About You
- Bachelor’s degree required.
- 4–6 years of experience in marketing, commercialization, consulting, or strategy roles within healthcare, diagnostics, medical devices, or life sciences.
- Demonstrated ability to translate complex information into clear, persuasive commercial messaging.
- Strong analytical and strategic thinking skills paired with hands-on execution.
- Experience developing sales enablement or customer-facing commercial materials.
- Excellent written, verbal, and presentation skills.
- Strong project management skills and comfort managing multiple workstreams.
- Proficiency in Microsoft PowerPoint, Word, and Excel.
- MBA or other business-focused graduate degree.
- Clinical background or degree a plus.
- Experience supporting speaker programs, webinars, or scientific symposia.
- Familiarity with emergency medicine, critical care, laboratory medicine, or hospital-based selling environments.
- Experience in a startup or high-growth company.
Benefits
- Competitive compensation including base salary, annual bonus, and equity.
- Meaningful opportunity for professional growth and expanded responsibility as Cytovale scales.
Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Our FDA cleared IntelliSep test is pioneering a new way of quickly and accurately analyzing white blood cells to stratify a patient’s risk of sepsis by performing a biomechanical evaluation of white blood cells collected from a standard blood draw in under 10 minutes. Cytovale’s first market application will be for sepsis, one of the fastest-moving, most lethal conditions in the world. Sepsis, a dysregulated immune response to infection, is often difficult to quickly and accurately diagnose. Sepsis is the no. 1 cause of death in hospitals, taking the lives of 270,000 people every year in the U.S. – more than opioid overdoses, prostate cancer, and breast cancer combined. Mortality from sepsis increases as much as eight percent with every hour of delayed treatment, and as much as 80 percent of sepsis deaths could be prevented with rapid diagnosis and treatment, making early detection essential. Cytovale aims to provide critical insight for early identification of patients at risk of having sepsis, in the time needed for it to be useful. Follow us on Twitter: twitter.com/cytovale